NCT01292824: Pilot Study of Hepatitis C Virus Entry Inhibitor (ITX 5061) in Liver Transplant Recipients |
|
|
| Completed | 1 | 24 | Europe | ITX 5061 | University of Birmingham, University Hospital Birmingham, National Institute for Health Research, United Kingdom | Hepatitis C, Evidence of Liver Transplantation | 01/13 | 05/13 | | |
NCT01560468: Study of Hepatitis C Virus (HCV) Entry Inhibitor in Liver Transplant Recipients With HCV Infection |
|
|
| Terminated | 1 | 10 | US | ITX 5061 | Schiano, Thomas D., MD, iTherX Pharmaceuticals Inc. | Hepatitis C Infection | 04/18 | 04/18 | | |
